FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kari Syrjänen

Research Profile

Living Beings

Papillomaviridae

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Cervix Uteri

Co-author Network

Publications

TOP 3
Kari Syrjänen; Stina Syrjänen
Detection of human papillomavirus in esophageal papillomas: systematic review and meta-analysis.
Karolina Louvanto; Jaana Rautava; Kari Syrjänen; Lilli Wideman; Jaana Willberg; Seija Grénman; Stina Syrjänen
Genotype-specific incidence and clearance of human papillomavirus in oral mucosa of women: a six-year follow-up study.
Kari Syrjänen; Stina Syrjänen
Detection of human papillomavirus in sinonasal papillomas: systematic review and meta-analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kari Syrjänen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kari Syrjänen; Stina Syrjänen
Detection of human papillomavirus in esophageal papillomas: systematic review and meta-analysis.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2013;121(5):363-74.
2013: Karolina Louvanto; Jaana Rautava; Kari Syrjänen; Lilli Wideman; Jaana Willberg; Seija Grénman; Stina Syrjänen
Genotype-specific incidence and clearance of human papillomavirus in oral mucosa of women: a six-year follow-up study.
PloS one 2013;8(1):e53413.
2013: Kari Syrjänen; Stina Syrjänen
Detection of human papillomavirus in sinonasal papillomas: systematic review and meta-analysis.
The Laryngoscope 2013;123(1):181-92.
2012: Eija Korkeila; Seppo Pyrhönen; Jari Sundström; Kari Syrjänen
Main effects and interactions of carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 in multivariate analysis for disease outcome in rectal cancer.
Anticancer research 2012;32(8):3299-303.
2012: Kari Syrjänen
Detection of human papillomavirus in lung cancer: systematic review and meta-analysis.
Anticancer research 2012;32(8):3235-50.
2012: Adhemar Longatto Filho; Marina Y S Maeda; Paulo Naud; Cecília Roteli-Martins; Luis Otavio Sarian; Stina Syrjänen; Sílvio Tatti; Margherita Branca; Silvano Costa; Jean Carlos de Matos; Sophie Fm Derchain; Mojca Eržen; Renata Gontijo; Luciano Serpa Hammes; Temístocles Lima; Kari Syrjänen
Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology.
Virchows Archiv : an international journal of pathology 2012;460(6):577-85.
2012: Pia Vihinen; Ilkka Koskivuo; Kari Syrjänen; Lauri Talve; Mari Vainio-Kaila; Seppo Pyrhönen
Previous pregnancy is a favourable prognostic factor in women with localised cutaneous melanoma.
Acta oncologica (Stockholm, Sweden) 2012;51(5):662-8.
2012: Hanna-Mari Koskimaa; Michael Pawlita; Kari Syrjänen; Seija Grénman; Tim Waterboer; Stina Syrjänen
Human papillomavirus genotypes present in the oral mucosa of newborns and their concordance with maternal cervical human papillomavirus genotypes.
The Journal of pediatrics 2012;160(5):837-43.
2012: Kari Syrjänen; T Vasankari; Eeva Salminen; M Silvoniemi; S Syrjänen
Detection of human papillomavirus genotypes in bronchial cancer using sensitive multimetrix assay.
Anticancer research 2012;32(2):625-31.
2012: Kari Syrjänen; Stina Syrjänen; Sílvio Tatti; S Zakharchenko; Margherita Branca; Marina Branovskaja; S Costa; Sophie Françoise Mauricette Derchain; Mojca Erzen; V Grunjberga; L Serpa Hammes; Anna Juschenko; Ludmila Kljukina; Vladimir Kozachenko; Adhemar Longatto Filho; Paulo Naud; Raisa Nerovjna; Jurij Podistov; Cecília Roteli-Martins; Luis Otávio Sarian; Irena Shabalova
Longitudinal outcomes of high-risk human papillomavirus (HPV) infections as competing-risks events following cervical HPV test at baseline visit in the NIS-LAMS cohort.
European journal of gynaecological oncology 2012;33(4):341-52.
2012: Jaana Rautava; Kari Syrjänen; Seija Grénman; Karolina Louvanto; Lilli Wideman; Jaana Willberg; Stina Syrjänen
Prevalence, genotype distribution and persistence of human papillomavirus in oral mucosa of women: a six-year follow-up study.
PloS one 2012;7(8):e42171.
2012: Kari Syrjänen; Stina Syrjänen; Sílvio Tatti; S Zakharchenko; Margherita Branca; Marina Branovskaja; S Costa; Sophie Françoise Mauricette Derchain; Mojca Erzen; V Grunjberga; Anna Juschenko; Ludmila Kljukina; Vladimir Kozachenko; Adhemar Longatto Filho; Paulo Naud; Raisa Nerovjna; Jurij Podistov; Cecília Roteli-Martins; Luis Otávio Sarian; L Serpa Hammes; Irena Shabalova
Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models.
European journal of gynaecological oncology 2012;33(1):5-14.
2011: Katja Kero; Jaana Rautava; Kari Syrjänen; Seija Grenman; Stina Syrjänen
Human papillomavirus genotypes in male genitalia and their concordance among pregnant spouses participating in the Finnish Family HPV study.
The journal of sexual medicine 2011;8(9):2522-31.
2011: Kari Syrjänen; Stina Syrjänen; Sílvio Tatti; S Zakharchenko; Margherita Branca; Marina Branovskaja; S Costa; Sophie Françoise Mauricette Derchain; M Eržen; V Grunjberga; L S Hammes; Anna Juschenko; Ludmila Kljukina; Vladimir Kozachenko; Adhemar Longatto Filho; Paulo Naud; Raisa Nerovjna; Jurij Podistov; Cecília Roteli-Martins; Luis Otávio Sarian; Irena Shabalova
Risk estimates for persistent high-risk human papillomavirus infections as surrogate endpoints of progressive cervical disease critically depend on reference category: analysis of the combined prospective cohort of the New Independent States of the Former Soviet Union and Latin American Screening studies.
International journal of STD & AIDS 2011;22(6):315-23.
2011: Kari Syrjänen; Stina Syrjänen; Sílvio Tatti; S Zakharchenko; Margherita Branca; Marina Branovskaja; S Costa; Sophie Françoise Mauricette Derchain; Mojca Erzen; V Grunjberga; L Serpa Hammes; Anna Juschenko; Ludmila Kljukina; Vladimir Kozachenko; Adhemar Longatto Filho; Paulo Naud; Raisa Nerovjna; Jurij Podistov; Cecília Roteli-Martins; Luis Otávio Sarian; Irena Shabalova
Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3.
International journal of STD & AIDS 2011;22(5):263-72.
2011: Kari Syrjänen
Persistent high-risk human papillomavirus (HPV) infections as surrogate endpoints of progressive cervical disease. Potential new endpoint for efficacy studies with new-generation (non-HPV 16/18) prophylactic HPV vaccines.
European journal of gynaecological oncology 2011;32(1):17-33.
2011: Eija Korkeila; P M Jaakkola; Kari Syrjänen; Seppo Pyrhönen; J Sundström
Pronounced tumour regression after radiotherapy is associated with negative/weak glucose transporter-1 expression in rectal cancer.
Anticancer research 2011;31(1):311-5.
2010: Kari Syrjänen; L Di Bonito; L Gonçalves; L Murjal; M Santamaria; V Mahovlic; P Karakitsos; B Onal; F C Schmitt
Cervical cancer screening in Mediterranean countries: implications for the future.
Cytopathology : official journal of the British Society for Clinical Cytology 2010;21(6):359-67.
2010: Hanna-Mari Koskimaa; Kaisa Kurvinen; Silvano Costa; Kari Syrjänen; Stina Syrjänen
Molecular markers implicating early malignant events in cervical carcinogenesis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(8):2003-12.
2010: Stina Syrjänen; Paulo Naud; Luis Otávio Sarian; Sophie Françoise Mauricette Derchain; Cecília Roteli-Martins; Silvio Tatti; Margherita Branca; Mojca Erzen; Luciano S Hammes; Silvano Costa; Adhemar Longatto Filho; Kari Syrjänen
Up-regulation of lipocalin 2 is associated with high-risk human papillomavirus and grade of cervical lesion at baseline but does not predict outcomes of infections or incident cervical intraepithelial neoplasia.
American journal of clinical pathology 2010;134(1):50-9.
2010: Johanna Palmroth; Proscovia Namujju; Aline Simen-Kapeu; Vesa Kataja; Heljä-Marja Surcel; Marjo Tuppurainen; Merja Yliskoski; Kari Syrjänen; Matti Lehtinen
Natural seroconversion to high-risk human papillomaviruses (hrHPVs) is not protective against related HPV genotypes.
Scandinavian journal of infectious diseases 2010;42(5):379-84.
2010: Stina Syrjänen; Paulo Naud; Luis Sarian; Sophie Derchain; Cecilia Roteli-Martins; Adhemar Longatto Filho; Silvio Tatti; Margherita Branca; Mojca Erzen; Luciano Serpa-Hammes; Jean Matos; Fernanda Arlindo; Marina Sakamoto-Maeda; Silvano Costa; Kari Syrjänen
p300 expression is related to high-risk human papillomavirus infections and severity of cervical intraepithelial neoplasia but not to viral or disease outcomes in a longitudinal setting.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2010;29(2):135-45.
2010: Stina Syrjänen; Paulo Naud; Luis Otávio Sarian; Sophie Françoise Mauricette Derchain; Cecília Roteli-Martins; Adhemar Longatto Filho; Silvio Tatti; Margherita Branca; Mojca Erzen; Luciano S Hammes; Silvano Costa; Kari Syrjänen
Up-regulation of 14-3-3sigma (Stratifin) is associated with high-grade CIN and high-risk human papillomavirus (HPV) at baseline but does not predict outcomes of HR-HPV infections or incident CIN in the LAMS study.
American journal of clinical pathology 2010;133(2):232-40.
2010: Luis Otávio Sarian; Sophie Françoise Mauricette Derchain; Irena Shabalova; Sílvio Tatti; Paulo Naud; Adhemar Longatto Filho; Stina Syrjänen; Kari Syrjänen
Optional screening strategies for cervical cancer using standalone tests and their combinations among low- and medium-income populations in Latin America and Eastern Europe.
Journal of medical screening 2010;17(4):195-203.
2010: Riyad Bendardaf; Abdelbaset Buhmeida; Marja Hilska; Matti Laato; Stina Syrjänen; Kari Syrjänen; Yrjö Collan; Seppo Pyrhönen
MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients.
Cancer investigation 2010;28(1):38-43.
2009: Stina Syrjänen; Paulo Naud; Luis Sarian; Sophie Derchain; Cecilia Roteli-Martins; Adhemar Longatto Filho; Silvio Tatti; Margerita Branca; Mojca Erzen; Luciano S Hammes; Silvano Costa; Kari Syrjänen
Up-regulation of plasminogen activator inhibitor-2 is associated with high-risk HPV and grade of cervical lesion at baseline but does not predict outcomes of high-risk HPV infections or incident CIN.
American journal of clinical pathology 2009;132(6):883-92.
2009: Stina Syrjänen; Paulo Naud; Luis Sarian; Sophie Derchain; Cecilia Roteli-Martins; Adhemar Longatto Filho; Silvio Tatti; Margherita Branca; Mojca Erzen; L S Hammes; S Costa; Kari Syrjänen
Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort.
Virchows Archiv : an international journal of pathology 2009;455(6):505-15.
2009: Kari Syrjänen; Irena Shabalova; Olga Ivanchenko; Ludmila Kljukina; Valerija Grunberga; Stina Syrjänen
Reproducibility of classification and correction for verification bias as determinants of performance of Papanicolaou smear cytology in the screening setting: experience from the New Independent States of the former Soviet Union cohort study.
Acta cytologica 2009;53(5):548-57.
2009: A Latvala; Kari Syrjänen; H Salmenoja; Eeva Salminen
Anaemia and other predictors of fatigue among patients on palliative therapy for advanced cancer.
Anticancer research 2009;29(7):2569-75.
2009: Kari Syrjänen; Irena Shabalova; Paulo Naud; Vladimir Kozachenko; Sophie Françoise Mauricette Derchain; Sergej Zakharchenko; Cecília Roteli-Martins; Raisa Nerovjna; Adhemar Longatto Filho; Ludmila Kljukina; Sílvio Tatti; Marina Branovskaja; Luciano Serpa Hammes; Margherita Branca; Valerija Grunjberga; Mojca Erzen; Luis Otávio Sarian; Anna Juschenko; Silvano Costa; Jurij Podistov; Stina Syrjänen
Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(5):934-42.
2009: Stina Syrjänen; Tim Waterboer; Marja Sarkola; Kristina M Michael; Marjut Rintala; Kari Syrjänen; Seija Grenman; Michael Pawlita
Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy.
The Journal of general virology 2009;90(Pt 6):1515-26.
2009: Eija Korkeila; K Talvinen; P M Jaakkola; Heikki Minn; Kari Syrjänen; J Sundström; Seppo Pyrhönen
Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer.
British journal of cancer 2009;100(6):874-80.
2009: Abdelbaset Buhmeida; Riyad Bendardaf; Marja Hilska; Yrjö Collan; Matti Laato; Stina Syrjänen; Kari Syrjänen; Seppo Pyrhönen
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma.
Journal of gastrointestinal cancer 2009;40(3-4):91-7.
2009: Denise Rocha Pitta; Luis Otávio Sarian; Elisabete Aparecida Campos; Silvia Helena Rabelo-Santos; Kari Syrjänen; Sophie Françoise Mauricette Derchain
Phylogenetic classification of human papillomavirus genotypes in high-grade cervical intraepithelial neoplasia in women from a densely populated Brazilian urban region.
São Paulo medical journal = Revista paulista de medicina 2009;127(3):122-7.
2009: Abdelbaset Buhmeida; Marja Hilska; Adam Ibrahim Elzagheid; Matti Laato; Yrjö Collan; Kari Syrjänen; Seppo Pyrhönen
DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.
Anticancer research 2009;29(1):99-106.
2009: Renata Guarisi; Luis Otavio Sarian; Luciano Serpa Hammes; Adhemar Longatto Filho; Sophie F M Derchain; Cecília Roteli-Martins; Paulo Naud; Mojca Erzen; Margherita Branca; Sílvio Tatti; Silvano Costa; Stina Syrjänen; Joana F Bragança; Kari Syrjänen
Smoking worsens the prognosis of mild abnormalities in cervical cytology.
Acta obstetricia et gynecologica Scandinavica 2009;88(5):514-20.
2008: Adam Ibrahim Elzagheid; Eija Korkeila; Riyad Bendardaf; Abdelbaset Buhmeida; Suvi Heikkilä; Antti Vaheri; Kari Syrjänen; Seppo Pyrhönen; Olli Carpén
Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
Human pathology 2008;39(12):1737-43.
2008: Riyad Bendardaf; Abdelbaset Buhmeida; Marja Hilska; Matti Laato; Stina Syrjänen; Kari Syrjänen; Yrjö Collan; Seppo Pyrhönen
VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival.
Anticancer research 2008;28(6B):3865-70.
2008: Riyad Bendardaf; Hanan Lamlum; Raija Ristamäki; Kari Syrjänen; Seppo Pyrhönen
Oncoprotein Bcl-2 and microsatellite instability are associated with disease-free survival and treatment response in colorectal cancer.
Oncology reports 2008;20(5):999-1004.
2008: Pia Vihinen; Ilkka Koskivuo; Kari Syrjänen; Taina Tervahartiala; Timo Sorsa; Seppo Pyrhönen
Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma.
Melanoma research 2008;18(4):268-73.
2008: Joseph Monsonego; Giuseppe Pollini; Marie José Evrard; Patrice Sednaoui; Laura Monfort; Dominique Quinzat; Roger Dachez; Kari Syrjänen
Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
International journal of STD & AIDS 2008;19(6):385-92.
2008: Joseph Monsonego; Giuseppe Pollini; Marie José Evrard; Patrice Sednaoui; Laura Monfort; Laurent Zerat; Kari Syrjänen
Detection of human papillomavirus genotypes among high-risk women: a comparison of hybrid capture and linear array tests.
Sexually transmitted diseases 2008;35(5):521-7.
2008: Stina Syrjänen; Kari Syrjänen
The history of papillomavirus research.
Central European journal of public health 2008;16 Suppl():S7-13.
2008: Kari Syrjänen; Paulo Naud; Sophie Françoise Mauricette Derchain; Cecília Roteli-Martins; Adhemar Longatto Filho; Sílvio Tatti; Margherita Branca; Mojca Erzen; L S Hammes; Jean Matos; Renata Clementino Gontijo; Luis Otávio Sarian; J Bragança; F C Arlindo; M Y S Maeda; A Lörincz; GB Dores; S Costa; Stina Syrjänen
Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia: case-control study nested within the Latin American Screening study cohort.
International journal of STD & AIDS 2008;19(4):251-8.
2008: Margherita Branca; Marco Ciotti; Colomba Giorgi; Donatella Santini; Luigi Di Bonito; Silvano Costa; Arrigo Benedetto; Donatella Bonifacio; Paola Di Bonito; Pierpaolo Paba; Luisa Accardi; Stina Syrjänen; Cartesio Favalli; Kari Syrjänen
Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2008;27(2):265-73.
2008: Laura Giuliani; Corrado Ronci; Daniela Bonifacio; Luigi Di Bonito; Cartesio Favalli; Carlo Federico Perno; Kari Syrjänen; Marco Ciotti
Detection of oncogenic DNA viruses in colorectal cancer.
Anticancer research 2008;28(2B):1405-10.
2008: Cristina Helena Rama; Cecília Roteli-Martins; Sophie Françoise Mauricette Derchain; Adhemar Longatto Filho; Renata Clementino Gontijo; Luis Otávio Sarian; Kari Syrjänen; José Mendes Aldrighi
[Prevalence of genital HPV infection among women screened for cervical cancer].
Revista de saúde pública 2008;42(1):123-30.
2008: Pierpaolo Paba; Donatella Bonifacio; Luigi Di Bonito; Domenico Ombres; Cartesio Favalli; Kari Syrjänen; Marco Ciotti
Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways.
Intervirology 2008;51(4):230-4.
2008: Kari Syrjänen
New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
European journal of gynaecological oncology 2008;29(3):205-21.
2008: Colomba Giorgi; Paola Di Bonito; Felicia Grasso; Stefania Mochi; Luisa Accardi; Maria Gabriella Donà; Margherita Branca; Silvano Costa; Luciano Mariani; Alberto Agarossi; Marco Ciotti; Kari Syrjänen
Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens.
Infectious agents and cancer 2008;3():9.
2008: Kari Syrjänen; S M Kulmala; Irena Shabalova; Nicolay Petrovichev; Vladimir Kozachenko; Tatjana Zakharova; Julia Pajanidi; Jurij Podistov; Galina Chemeris; Larisa Sozaeva; Elena Lipova; Irena Tsidaeva; Olga Ivanchenko; Alla Pshepurko; Sergej Zakharenko; Raisa Nerovjna; Ludmila Kljukina; Oksana Erokhina; Marina Branovskaja; Maritta Nikitina; V Grunjberga; A Grunjberg; Anna Juschenko; Rosa Santopietro; Marcella Cintorino; Piero Tosi; Stina Syrjänen
Epidemiological, clinical and viral determinants of the increased prevalence of high-risk human papillomavirus (HPV) infections in elderly women.
European journal of gynaecological oncology 2008;29(2):114-22.
2008: Kari Syrjänen; Irena Shabalova; Nicolay Petrovichev; Vladimir Kozachenko; Tatjana Zakharova; Julia Pajanidi; Jurij Podistov; Galina Chemeris; Larisa Sozaeva; Elena Lipova; Irena Tsidaeva; Olga Ivanchenko; Alla Pshepurko; Sergej Zakharenko; Raisa Nerovjna; Ludmila Kljukina; Oksana Erokhina; Marina Branovskaja; Maritta Nikitina; Valerija Grunberga; Alexandr Grunberg; Anna Juschenko; Rosa Santopietro; Marcella Cintorino; Piero Tosi; Stina Syrjänen
Age at menarche is not an independent risk factor for high-risk human papillomavirus infections and cervical intraepithelial neoplasia.
International journal of STD & AIDS 2008;19(1):16-25.
2008: Riyad Bendardaf; Hanan Lamlum; Raija Ristamäki; Eija Korkeila; Kari Syrjänen; Seppo Pyrhönen
Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.
Acta oncologica (Stockholm, Sweden) 2008;47(6):1046-53.
2007: Riyad Bendardaf; Abdelbaset Buhmeida; Raija Ristamäki; Kari Syrjänen; Seppo Pyrhönen
MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases.
Scandinavian journal of gastroenterology 2007;42(12):1473-8.
2007: Mauro Alderisio; Margherita Branca; Mojca Erzen; Adhemar Longatto Filho; Sophie Françoise Mauricette Derchain; Sílvio Tatti; Susana Vighi; Cecília Roteli-Martins; Luciano Leoncini; Marina Y S Maeda; Douglas Montis; Renata Clementino Gontijo; Luis Otávio Sarian; Kari Syrjänen
Interlaboratory quality control in gynecologic cytopathology using the novel CONQUISTADOR software. Interobserver reproducibility in the Latin American screening study.
Acta cytologica 2007;51(6):872-81.
2007: Riyad Bendardaf; Adam Ibrahim Elzagheid; Hanan Lamlum; Annika Algars; Eija Korkeila; Raija Ristamäki; Yrjö Collan; Kari Syrjänen; Seppo Pyrhönen
Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastases.
Scandinavian journal of gastroenterology 2007;42(4):471-6.
2007: Margherita Branca; Marco Ciotti; Colomba Giorgi; Daniele Santini; Luigi Di Bonito; Silvano Costa; Arrigo Benedetto; Donatella Bonifacio; Paola Di Bonito; Pierpaolo Paba; Luisa Accardi; Stina Syrjänen; Cartesio Favalli; Kari Syrjänen
Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer.
European journal of obstetrics, gynecology, and reproductive biology 2007;130(2):223-31.
2007: Kari Syrjänen
Mechanisms and predictors of high-risk human papillomavirus (HPV) clearance in the uterine cervix.
European journal of gynaecological oncology 2007;28(5):337-51.
2007: Kari Syrjänen; Irena Shabalova; Nicolay Petrovichev; Vladimir Kozachenko; Tatjana Zakharova; Julia Pajanidi; Jurij Podistov; Galina Chemeris; Larisa Sozaeva; Elena Lipova; Irena Tsidaeva; Olga Ivanchenko; Alla Pshepurko; Sergej Zakharenko; Raisa Nerovjna; Ludmila Kljukina; Oksana Erokhina; Marina Branovskaja; Maritta Nikitina; Valerija Grunberga; Alexandr Grunberg; Anna Juschenko; Rosa Santopietro; Marcella Cintorino; Piero Tosi; Stina Syrjänen
Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade CIN.
European journal of epidemiology 2007;22(10):723-35.
2007: Riyad Bendardaf; Hanan Lamlum; Raija Ristamäki; Eija Korkeila; Kari Syrjänen; Seppo Pyrhönen
Mismatch repair status is a predictive factor of tumour response to 5-fluorouracil and irinotecan chemotherapy in patients with advanced colorectal cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2007;28(4):212-20.
2006: Kari Syrjänen; Irena Shabalova; Nicolay Petrovichev; Vladimir Kozachenko; Tatjana Zakharova; Julia Pajanidi; Jurij Podistov; Galina Chemeris; Larisa Sozaeva; Elena Lipova; Irena Tsidaeva; Olga Ivanchenko; Alla Pshepurko; Sergej Zakharenko; Raisa Nerovjna; Ludmila Kljukina; Oksana Erokhina; Marina Branovskaja; Maritta Nikitina; Valerija Grunberga; Alexandr Grunberg; Anna Juschenko; Rosa Santopietro; Marcella Cintorino; Piero Tosi; Stina Syrjanen
Oral contraceptives are not an independent risk factor for cervical intraepithelial neoplasia or high-risk human papillomavirus infections.
Anticancer research 2006;26(6C):4729-40.
2006: Margherita Branca; Colomba Giorgi; Marco Ciotti; Daniele Santini; Luigi Di Bonito; Silvano Costa; Arrigo Benedetto; Donatella Bonifacio; Paola Di Bonito; Pierpaolo Paba; Luisa Accardi; Luciano Mariani; Merja Ruutu; Stina Syrjänen; Cartesio Favalli; Kari Syrjänen
Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer.
Diagnostic cytopathology 2006;34(11):739-48.
2006: Margherita Branca; Colomba Giorgi; Marco Ciotti; Daniele Santini; Luigi Di Bonito; Silvano Costa; Arrigo Benedetto; Donatella Bonifacio; Paola Di Bonito; Pierpaolo Paba; Luisa Accardi; Luciano Mariani; Merja Ruutu; Stina Syrjänen; Cartesio Favalli; Kari Syrjänen
Over-expression of topoisomerase IIalpha is related to the grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict prognosis in cervical cancer or HPV clearance after cone treatment.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2006;25(4):383-92.
2006: Riyad Bendardaf; Annika Algars; Adam Ibrahim Elzagheid; Eija Korkeila; Raija Ristamäki; Hanan Lamlum; Yrjö Collan; Kari Syrjänen; Seppo Pyrhönen
Comparison of CD44 expression in primary tumours and metastases of colorectal cancer.
Oncology reports 2006;16(4):741-6.
2006: Margherita Branca; Colomba Giorgi; Marco Ciotti; Daniele Santini; Luigi Di Bonito; Silvano Costa; Arrigo Benedetto; Donatella Bonifacio; Paola Di Bonito; Pierpaolo Paba; Luisa Accardi; Luciano Mariani; Merja Ruutu; Cartesio Favalli; Kari Syrjänen
Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer.
Journal of clinical pathology 2006;59(10):1044-51.
2006: Laura Giuliani; Anna Coletti; Kari Syrjänen; Cartesio Favalli; Marco Ciotti
Comparison of DNA sequencing and Roche Linear array in human papillomavirus (HPV) genotyping.
Anticancer research 2006;26(5B):3939-41.
2006: Margherita Branca; Colomba Giorgi; Marco Ciotti; Daniele Santini; Luigi Di Bonito; Silvano Costa; Arrigo Benedetto; Donatella Bonifacio; Paola Di Bonito; Pierpaolo Paba; Luisa Accardi; Luciano Mariani; Merja Ruutu; Stina Syrjänen; Cartesio Favalli; Kari Syrjänen
Upregulation of nuclear factor-kappaB (NF-kappaB) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus or disease outcome in cervical cancer.
Diagnostic cytopathology 2006;34(8):555-63.
2006: Rosa Santopietro; Irena Shabalova; Nicolay Petrovichev; Vladimir Kozachenko; Tatjana Zakharova; Julia Pajanidi; Jurij Podistov; Galina Chemeris; Larisa Sozaeva; Elena Lipova; Irena Tsidaeva; Olga Ivanchenko; Alla Pshepurko; Sergej Zakharenko; Raisa Nerovjna; Ludmila Kljukina; Oksana Erokhina; Marina Branovskaja; Maritta Nikitina; Valerija Grunberga; Alexandr Grunberg; Anna Juschenko; Marcella Cintorino; Piero Tosi; Kari Syrjänen; Stina Syrjänen
Cell cycle regulators p105, p107, Rb2/p130, E2F4, p21CIP1/WAF1, cyclin A in predicting cervical intraepithelial neoplasia, high-risk human papillomavirus infections and their outcome in women screened in three new independent states of the former Soviet Union.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(7):1250-6.
2006: Marco Ciotti; Laura Giuliani; Vincenzo Ambrogi; Corrado Ronci; Arrigo Benedetto; Tommaso Claudio Mineo; Kari Syrjänen; Cartesio Favalli
Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer.
Oncology reports 2006;16(1):183-9.
2006: Merja Ruutu; N Wahlroos; Kari Syrjänen; Bo Johansson; Stina Syrjänen
Effects of 17beta-estradiol and progesterone on transcription of human papillomavirus 16 E6/E7 oncogenes in CaSki and SiHa cell lines.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(3):1261-8.
2006: Adhemar Longatto Filho; Mojca Erzen; Margherita Branca; Cecília Roteli-Martins; Paulo Naud; Sophie Françoise Mauricette Derchain; Luciano Hammes; Luis Otávio Sarian; Joana F Bragança; Jean Matos; Renata Clementino Gontijo; Temístocles P Lima; M Y S Maeda; Sílvio Tatti; Stina Syrjänen; GB Dores; A Lörincz; Kari Syrjänen
Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(3):955-62.
2006: Margherita Branca; Marco Ciotti; Colomba Giorgi; Daniele Santini; Luigi Di Bonito; Silvano Costa; Arrigo Benedetto; Donatella Bonifacio; Paola Di Bonito; Pierpaolo Paba; Luisa Accardi; Stina Syrjänen; Cartesio Favalli; Kari Syrjänen
Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.
Anticancer research 2006;26(2B):1543-56.
2006: Abdelbaset Buhmeida; Annika Algars; Raija Ristamäki; Yrjö Collan; Kari Syrjänen; Seppo Pyrhönen
DNA image cytometry is a useful adjunct tool in the prediction of disease outcome in patients with stage II and stage III colorectal cancer.
Oncology 2006;70(6):427-37.
2006: Paola Di Bonito; Felicia Grasso; Stefania Mochi; Luisa Accardi; Maria Gabriella Donà; Margherita Branca; Silvano Costa; Luciano Mariani; Alberto Agarossi; Marco Ciotti; Kari Syrjänen; Colomba Giorgi
Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins.
Infectious agents and cancer 2006;1():6.
2006: Margherita Branca; Colomba Giorgi; Marco Ciotti; Daniele Santini; Luigi Di Bonito; Silvano Costa; Arrigo Benedetto; Donatella Bonifacio; Paola Di Bonito; Pierpaolo Paba; Luisa Accardi; Luciano Mariani; Stina Syrjänen; Cartesio Favalli; Kari Syrjänen
Down-regulation of E-cadherin is closely associated with progression of cervical intraepithelial neoplasia (CIN), but not with high-risk human papillomavirus (HPV) or disease outcome in cervical cancer.
European journal of gynaecological oncology 2006;27(3):215-23.
2006: Abdelbaset Buhmeida; Annika Algars; Raija Ristamäki; Yrjö Collan; Kari Syrjänen; Seppo Pyrhönen
Nuclear size as prognostic determinant in stage II and stage III colorectal adenocarcinoma.
Anticancer research 2006;26(1B):455-62.
2006: Margherita Branca; Colomba Giorgi; Marco Ciotti; Daniele Santini; Luigi Di Bonito; Silvano Costa; Arrigo Benedetto; Donatella Bonifacio; Paola Di Bonito; Pierpaolo Paba; Luisa Accardi; Luciano Mariani; Stina Syrjänen; Cartesio Favalli; Kari Syrjänen
Relationship of up-regulation of 67-kd laminin receptor to grade of cervical intraepithelial neoplasia and to high-risk HPV types and prognosis in cervical cancer.
Acta cytologica 2006;50(1):6-15.
2006: Margherita Branca; Colomba Giorgi; Daniele Santini; Luigi Di Bonito; Marco Ciotti; Arrigo Benedetto; Pierpaolo Paba; Silvano Costa; Donatella Bonifacio; Paola Di Bonito; Luisa Accardi; Cartesio Favalli; Kari Syrjänen
Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.
Journal of clinical pathology 2006;59(1):40-7.
2006: Paulo Naud; Jean Matos; Luciano Hammes; J Stuckzynski; K Brouwers; V Magno; E Dias; P Crusius; A d'Avila; C Campos; M Costa; M Höblik; C Marc; R Marroni; Kari Syrjänen
Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of Brazil.
European journal of obstetrics, gynecology, and reproductive biology 2006;124(1):110-8.
2005: Suely Nonogaki; Alda Wakamatsu; Adhemar Longatto Filho; Cecília Roteli-Martins; Celso Di Loreto; Marina Yoshiê Sakamoto Maeda; Maria Lúcia Utagawa; Sônia Maria Miranda Pereira; Sabrina Polli; Venâncio A F Alves; Kari Syrjänen
Molecular strategies for identifying human papillomavirus infection in routinely processed samples: focus on paraffin sections.
Journal of lower genital tract disease 2005;9(4):219-24.
2005: Adhemar Longatto Filho; Marina Yoshiê Sakamoto Maeda; Mojca Erzen; Margherita Branca; Cecília Roteli-Martins; Paulo Naud; Sophie Françoise Mauricette Derchain; Luciano Hammes; Jean Matos; Renata Clementino Gontijo; Luis Otávio Sarian; Temístocles P Lima; Sílvio Tatti; Stina Syrjänen; Kari Syrjänen
Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.
Acta cytologica 2005;49(5):500-6.
2005: Kari Syrjänen; Paulo Naud; Sophie Françoise Mauricette Derchain; Cecília Roteli-Martins; Adhemar Longatto Filho; Sílvio Tatti; Margherita Branca; Mojca Erzen; Luciano Hammes; Jean Matos; Renata Clementino Gontijo; Luis Otávio Sarian; J Braganca; F C Arlindo; M Y S Maeda; A Lörincz; GB Dores; S Costa; Stina Syrjänen
Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study.
Anticancer research 2005;25(5):3469-80.
2005: Margherita Branca; Pierluigi Morosini; Pierluigi Severi; Mojca Erzen; Claudio Di Benedetto; Kari Syrjänen
New statistical software for intralaboratory and interlaboratory quality control in clinical cytology. Validation in a simulation study on clinical samples.
Acta cytologica 2005;49(4):398-404.
2005: Abdelbaset Buhmeida; Raija Ristamäki; Hanan Lamlum; Riyad Bendardaf; Suvi Heikkilä; Yrjö Collan; Kari Syrjänen; Seppo Pyrhönen
Nuclear area is a prognostic determinant in advanced colorectal cancer.
Anticancer research 2005;25(4):3083-8.
2005: Margherita Branca; Colomba Giorgi; Daniele Santini; Luigi Di Bonito; Marco Ciotti; Silvano Costa; Arrigo Benedetto; Elena A Casolati; Cartesio Favalli; Pierpaolo Paba; Paola Di Bonito; Luciano Mariani; Stina Syrjänen; Donatella Bonifacio; Luisa Accardi; Fabrizio Zanconati; Kari Syrjänen
Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer.
American journal of clinical pathology 2005;124(1):113-21.
2005: Adhemar Longatto Filho; Maria Lúcia Utagawa; Neuza Kasumi Shirata; Sônia Maria Miranda Pereira; Gislene M Namiyama; Cristina Takami Kanamura; Gilda da Cunha Santos; Marilene Almeida de Oliveira; Alda Wakamatsu; Suely Nonogaki; Cecília Roteli-Martins; Celso Di Loreto; Maria da Gloria Mattosinho de Castro Ferraz; Marina Yoshiê Sakamoto Maeda; Venâncio A F Alves; Kari Syrjänen
Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2005;24(2):118-24.
2005: Stina Syrjänen; Irena Shabalova; Nicolay Petrovichev; Jurij Podistov; Olga Ivanchenko; Sergej Zakharenko; Raisa Nerovjna; Ludmila Kljukina; Marina Branovskaja; Anna Juschenko; Piero Tosi; Kari Syrjänen
Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union.
International journal of STD & AIDS 2005;16(3):217-23.
2005: Stina Syrjänen; Irena Shabalova; Nicolay Petrovichev; Vladimir Kozachenko; Tatjana Zakharova; Julia Pajanidi; Jurij Podistov; Galina Chemeris; Larisa Sozaeva; Elena Lipova; Irena Tsidaeva; Olga Ivanchenko; Alla Pshepurko; Sergej Zakharenko; Raisa Nerovjna; Ludmila Kljukina; Oksana Erokhina; Marina Branovskaja; Maritta Nikitina; Valerija Grunberga; Alexandr Grunberg; Anna Juschenko; Marcella Cintorino; Rosa Santopietro; Piero Tosi; Kari Syrjänen
Factors predicting persistence of high-risk human papillomavirus (HPV) infections in women prospectively followed-up in three New Independent States (NIS) of the former Soviet Union.
European journal of gynaecological oncology 2005;26(5):491-8.
2005: Luis Otávio Sarian; Sophie Françoise Mauricette Derchain; Paulo Naud; Cecília Roteli-Martins; Adhemar Longatto Filho; Sílvio Tatti; Margherita Branca; Mojca Erzen; L Serpa-Hammes; Jean Matos; Renata Clementino Gontijo; Joana F Bragança; Temístocles P Lima; M Y S Maeda; A Lörincz; GB Dores; S Costa; Stina Syrjänen; Kari Syrjänen
Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Journal of medical screening 2005;12(3):142-9.
2004: Margherita Branca; Marco Ciotti; Daniele Santini; Luigi Di Bonito; Arrigo Benedetto; Colomba Giorgi; Pierpaolo Paba; Cartesio Favalli; Silvano Costa; Alberto Agarossi; Mauro Alderisio; Kari Syrjänen
Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer.
American journal of clinical pathology 2004;122(6):902-11.
2004: Neuza Kasumi Shirata; Luiz Marcelo Warneck Espoladore; Adhemar Longatto Filho; Janaína Erica Pittoli; Celso Di Loreto; Sônia Maria Miranda Pereira; Marina Yoshie Sakamoto Maeda; Maria Lúcia Utagawa; Luciana da Silva Aguiar; Cecília Roteli-Martins; Edson G Martinez; Kari Syrjänen
High-risk HPV detection by Hybrid Capture and ploidy determination by a computer-assisted system in cervical biopsies.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2004;26(5):295-300.
2004: Margherita Branca; Marco Ciotti; Daniele Santini; Luigi Di Bonito; Colomba Giorgi; Arrigo Benedetto; Pierpaolo Paba; Cartesio Favalli; Silvano Costa; Alberto Agarossi; Mauro Alderisio; Kari Syrjänen
p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2004;23(4):354-65.
2004: Merja Ruutu; Bo Johansson; Reidar Grenman; Kari Syrjänen; Stina Syrjänen
Effect of confluence state and passaging on global cancer gene expression pattern in oral carcinoma cell lines.
Anticancer research 2004;24(5A):2627-31.
2004: Suely Nonogaki; Alda Wakamatsu; Adhemar Longatto Filho; Sônia Maria Miranda Pereira; Maria Lúcia Utagawa; Venâncio Avancini Ferreira Alves; Celso Di Loreto; Marina Yoshiê Sakamoto Maeda; Temístocles P Lima; Cecília Roteli-Martins; Kari Syrjänen
Hybrid capture II and polymerase chain reaction for identifying HPV infections in samples collected in a new collection medium: a comparison.
Acta cytologica 2004;48(4):514-20.
2004: Satu-Maria A Kulmala; Stina Syrjänen; Irena Shabalova; Nicolay Petrovichev; Vladimir Kozachenko; Jurij Podistov; Olga Ivanchenko; Sergej Zakharenko; Raisa Nerovjna; Ludmila Kljukina; Marina Branovskaja; Valerija Grunberga; Anna Juschenko; Piero Tosi; Rosa Santopietro; Kari Syrjänen
Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools.
Journal of clinical microbiology 2004;42(6):2470-5.
2004: Stina Syrjänen; Irena Shabalova; Nicolay Petrovichev; Vladimir Kozachenko; Tatjana Zakharova; Julia Pajanidi; Jurij Podistov; Galina Chemeris; Larisa Sozaeva; Elena Lipova; Irena Tsidaeva; Olga Ivanchenko; Alla Pshepurko; Sergej Zakharenko; Raisa Nerovjna; Ludmila Kljukina; Oksana Erokhina; Marina Branovskaja; Maritta Nikitina; Valerija Grunberga; Alexandr Grunberg; Anna Juschenko; Piero Tosi; Marcella Cintorino; Rosa Santopietro; Kari Syrjänen
Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the New Independent States of the Former Soviet Union.
Journal of clinical microbiology 2004;42(2):505-11.
2004: Margherita Branca; Silvano Costa; Luciano Mariani; Francesco Sesti; Alberto Agarossi; A di Carlo; M Galati; Arrigo Benedetto; Marco Ciotti; Colomba Giorgi; Anna Angela Criscuolo; Monica Valieri; Cartesio Favalli; Pierpaolo Paba; Daniele Santini; Emilio Piccione; Mauro Alderisio; Maria De Nuzzo; Luigi Di Bonito; Kari Syrjänen
Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.
European journal of gynaecological oncology 2004;25(6):689-98.
2004: Marco Ciotti; Francesco Sesti; Pierpaolo Paba; Arrigo Benedetto; L Patrizi; Anna Angela Criscuolo; Emilio Piccione; Margherita Branca; Kari Syrjänen; Cartesio Favalli
Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
European journal of gynaecological oncology 2004;25(5):577-84.
2003: Stina Syrjänen; Irena Shabalova; Nicolay Petrovichev; Vladimir Kozachenko; Tatjana Zakharova; Julia Pajanidi; Jurij Podistov; Galina Chemeris; Larisa Sozaeva; Elena Lipova; Irena Tsidaeva; Olga Ivanchenko; Alla Pshepurko; Sergej Zakharenko; Raisa Nerovjna; Ludmila Kljukina; Oksana Erokhina; Marina Branovskaja; Maritta Nikitina; Valerija Grujnberga; Alexandr Grujnberg; Anna Juschenko; Bo Johansson; Piero Tosi; Marcella Cintorino; Rosa Santopietro; Kari Syrjänen
Sexual habits and human papillomavirus infection among females in three New Independent States of the former Soviet Union.
Sexually transmitted diseases 2003;30(9):680-4.
2003: Neuza Kasumi Shirata; Adhemar Longatto Filho; Cecília Roteli-Martins; Luiz Marcelo W Espoladore; Janaína Erika Pittoli; Kari Syrjänen
Applicability of liquid-based cytology to the assessment of DNA content in cervical lesions using static cytometry.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2003;25(4):210-4.
2003: Silvano Costa; Pia De Simone; Stefano Venturoli; Monica Cricca; Marialuisa Zerbini; Monica Musiani; Patrizia Terzano; Daniele Santini; Paolo Cristiani; Stina Syrjänen; Kari Syrjänen
Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization.
Gynecologic oncology 2003;90(2):358-65.
2003: Margherita Branca; Anna Rosa Garbuglia; Arrigo Benedetto; T Cappiello; Luciano Leoncini; G Migliore; Alberto Agarossi; Kari Syrjänen
Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
International journal of STD & AIDS 2003;14(6):417-25.
2002: Mojca Erzen; Andrej Mozina; J Bertole; Kari Syrjänen
Factors predicting disease outcome in early stage adenocarcinoma of the uterine cervix.
European journal of obstetrics, gynecology, and reproductive biology 2002;101(2):185-91.
2001: Marcella Cintorino; S A Tripod; Rosa Santopietro; P Antonio; A Lutfi; F Chang; Stina Syrjänen; Q Shen; Piero Tosi; Kari Syrjänen
Cytokeratin expression patterns as an indicator of tumour progression in oesophageal squamous cell carcinoma.
Anticancer research 2001;21(6A):4195-201.
2001: Silvano Costa; Patrizia Terzano; Daniele Santini; C Ceccarelli; Andrea Martoni; B Angelelli; A Panetta; Alessandro Bovicelli; Paolo Cristiani; P Lipponen; M Erzén; Stina Syrjänen; Kari Syrjänen
Neoadjuvant chemotherapy in cervical carcinoma: regulators of cell cycle, apoptosis, and proliferation as determinants of response to therapy and disease outcome.
American journal of clinical pathology 2001;116(5):729-37.
2001: Mojca Erzen; Stelio Rakar; B Klancnik; Kari Syrjänen; B Klancar
Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.
Gynecologic oncology 2001;83(1):100-8.
2001: Margherita Branca; E Rossi; Mauro Alderisio; G Migliore; Pierluigi Morosini; Aldo Vecchione; F Sopracordevole; Pierpaolo Mudu; Luciano Leoncini; Kari Syrjänen
Performance of cytology and colposcopy in diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-positive and HIV-negative women.
Cytopathology : official journal of the British Society for Clinical Cytology 2001;12(2):84-93.
2001: Silvano Costa; Patrizia Terzano; Alessandro Bovicelli; Andrea Martoni; B Angelelli; Daniele Santini; C Ceccarelli; P Lipponen; M Erzén; Stina Syrjänen; Kari Syrjänen
CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.
Gynecologic oncology 2001;80(1):67-73.
2000: Sergio Antonio Tripodi; F Chang; Stina Syrjänen; Q Shen; Marcella Cintorino; L Alia; Rosa Santopietro; Piero Tosi; Kari Syrjänen
Quantitative image analysis of oesophageal squamous cell carcinoma from the high-incidence area of China, with special reference to tumour progression and papillomavirus (HPV) involvement.
Anticancer research 2000;20(5C):3855-62.
2000: Maarit Anttila; Jari K Kellokoski; KI Moisio; P J Mitchell; Seppo Saarikoski; Kari Syrjänen; Veli-Matti Kosma
Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer.
British journal of cancer 2000;82(12):1974-83.
2000: Silvano Costa; Mario Sideri; Kari Syrjänen; Patrizia Terzano; Maria De Nuzzo; Pia De Simone; Paolo Cristiani; A C Finarelli; Alessandro Bovicelli; Alessandra Zamparelli; Luciano Bovicelli
Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer.
Acta cytologica 2000;44(3):310-8.
2000: F Chang; S Syrjänen; Q Shen; M Cintorino; Rosa Santopietro; P Tosi; Kari Syrjänen
Human papillomavirus involvement in esophageal carcinogenesis in the high-incidence area of China. A study of 700 cases by screening and type-specific in situ hybridization.
Scandinavian journal of gastroenterology 2000;35(2):123-30.
1999: Sirpa Aaltomaa; Pertti Lipponen; Martti Ala-Opas; Matti Eskelinen; Kari Syrjänen; Veli-Matti Kosma
Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
British journal of cancer 1999;80(12):2001-7.
1999: S Lu; Jaakko Tiekso; Sakari Hietanen; Kari Syrjänen; Väinö K Havu; Stina Syrjänen
Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Acta dermato-venereologica 1999;79(4):268-73.
1999: Maarit Anttila; Veli-Matti Kosma; J Hongxiu; Jukka Puolakka; Matti Juhola; Seppo Saarikoski; Kari Syrjänen
p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer.
British journal of cancer 1999;79(11-12):1870-8.
1999: Maarit Anttila; S Syrjänen; Hongxiu Ji; Seppo Saarikoski; Kari Syrjänen
Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR.
Gynecologic oncology 1999;72(3):337-41.
1998: Sakari Hietanen; E Auvinen; Kari Syrjänen; Stina Syrjänen
Anti-proliferative effect of retinoids and interferon-alpha-2a on vaginal cell lines derived from squamous intra-epithelial lesions.
International journal of cancer. Journal international du cancer 1998;78(3):338-45.
1998: Kari Syrjänen
Anogenital human papilloma virus and the problem of persistence.
European journal of dermatology : EJD 1998;8(7 Suppl):5-7; discussion 20-2.
1998: Maarit Anttila; Veli-Matti Kosma; Hongxiu Ji; X Wei-Ling; Jukka Puolakka; Matti Juhola; Seppo Saarikoski; Kari Syrjänen
Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2591-600.
1998: Sakari Hietanen; Kari Syrjänen; Stina Syrjänen
Characterization of keratin and cell cycle protein expression in cell lines from squamous intraepithelial lesions progressing towards a malignant phenotype.
British journal of cancer 1998;77(5):766-75.
1997: Sakari Hietanen; Ulla Ekblad; Tarja-Terttu Pelliniemi; Kari Syrjänen; Hans Helenius; Stina Syrjänen
Type I diabetic pregnancy and subclinical human papillomavirus infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(2):153-6.
1997: E Suonio; Pertti Lipponen; Jukka Mäenpää; Kari Syrjänen; Lauri Kangas; L Tuomisto
Mitotic index in the subrenal capsule assay as an indicator of the chemosensitivity of ovarian cancer.
Cancer chemotherapy and pharmacology 1997;41(1):15-21.
1997: Sirpa Aaltomaa; Pertti Lipponen; S Vesalainen; Martti Ala-Opas; Matti Eskelinen; Kari Syrjänen
Value of Ki-67 immunolabelling as a prognostic factor in prostate cancer.
European urology 1997;32(4):410-5.
1997: Sirpa Aaltomaa; Pertti Lipponen; Martti Ala-Opas; Matti Eskelinen; Kari Syrjänen
Prognostic value of Ki-67 expression in renal cell carcinomas.
European urology 1997;31(3):350-5.
1997: F Chang; S Syrjänen; L Wang; Q Shen; Kari Syrjänen
p53 overexpression and human papillomavirus (HPV) infection in oesophageal squamous cell carcinomas derived from a high-incidence area in China.
Anticancer research 1997;17(1B):709-15.
1997: Risto Pirinen; Pertti Lipponen; Sirpa Aaltomaa; Kari Syrjänen
Prognostic value of epidermal growth factor expression in breast cancer.
Journal of cancer research and clinical oncology 1997;123(1):63-8.
1996: S Lu; Kari Syrjänen; Väinö K Havu; Stina Syrjänen
Failure to demonstrate human papillomavirus (HPV) involvement in Bowen's disease of the skin.
Archives of dermatological research 1996;289(1):40-5.
1996: S Lu; Kari Syrjänen; Väinö K Havu; Stina Syrjänen
Expression of PCNA is associated with the presence of HPV DNA in skin warts.
Archives of dermatological research 1996;289(1):35-9.
1996: Z Zhu; M Parviainen; S Männistö; P Pietinen; Matti Eskelinen; Kari Syrjänen; Matti Uusitupa
Vitamin E concentration in breast adipose tissue of breast cancer patients (Kuopio, Finland).
Cancer causes & control : CCC 1996;7(6):591-5.
1996: K Lappalainen; L Pirilä; Ilpo Jääskeläinen; Kari Syrjänen; Stina Syrjänen
Effects of liposomal antisense oligonucleotides on mRNA and protein levels of the HPV 16 E7 oncogene.
Anticancer research 1996;16(5A):2485-92.
1996: Hongxiu Ji; M Yliskoski; M Anttila; Kari Syrjänen; S Saarikoski
Management of stage-I borderline ovarian tumors.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 1996;54(1):37-44.
1996: Pertti Lipponen; S Vesalainen; J Kasurinen; Martti Ala-Opas; Kari Syrjänen
A prognostic score for prostatic adenocarcinoma based on clinical, histological, biochemical and cytometric data from the primary tumour.
Anticancer research 1996;16(4A):2095-100.
1996: K Kurvinen; Kari Syrjänen; Stina Syrjänen
p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(7):2120-30.
1996: Kari Syrjänen; T Nurmi; Rauno Mäntyjärvi; J Ilonen; Stina Syrjänen; Heljä-Marja Surcel; M Yliskoski; M Väyrynen; F Chang; S Saarikoski
HLA types in women with cervical human papillomavirus (HPV) lesions prospectively followed up for 10 years.
Cytopathology : official journal of the British Society for Clinical Cytology 1996;7(2):99-107.
1996: Matti Puranen; M Yliskoski; S Saarikoski; Kari Syrjänen; Stina Syrjänen
Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood.
American journal of obstetrics and gynecology 1996;174(2):694-9.
1996: T Pietiläinen; Pertti Lipponen; Sirpa Aaltomaa; Matti Eskelinen; Veli-Matti Kosma; Kari Syrjänen
The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer.
Journal of cancer research and clinical oncology 1996;122(11):687-92.
1996: Matti Puranen; Kari Syrjänen; Stina Syrjänen
Transmission of genital human papillomavirus infections is unlikely through the floor and seats of humid dwellings in countries of high-level hygiene.
Scandinavian journal of infectious diseases 1996;28(3):243-6.
1995: R Pirinen; Pertti Lipponen; Kari Syrjänen
Expression of epidermal growth factor receptor (EGFR) in breast cancer as related to clinical, prognostic and cytometric factors.
Anticancer research 1995;15(6B):2835-40.
1995: P Auvinen; Pertti Lipponen; R Johansson; Kari Syrjänen
Prognostic significance of TGF-beta 1 and TGF-beta 2 expressions in female breast cancer.
Anticancer research 1995;15(6B):2627-31.
1995: T Pietiläinen; Pertti Lipponen; Sirpa Aaltomaa; Matti Eskelinen; Veli-Matti Kosma; Kari Syrjänen
Expression of p53 protein has no independent prognostic value in breast cancer.
The Journal of pathology 1995;177(3):225-32.
1995: Sakari Hietanen; K Kurvinen; Kari Syrjänen; Seija Grénman; Thomas Carey; K McClatchey; Stina Syrjänen
Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
American journal of obstetrics and gynecology 1995;173(5):1477-82.
1995: Pertti Lipponen; T Pietiläinen; Veli-Matti Kosma; Sirpa Aaltomaa; Matti Eskelinen; Kari Syrjänen
Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis.
The Journal of pathology 1995;177(1):49-55.
1995: S Vesalainen; Pertti Lipponen; M Talja; J Kasurinen; Kari Syrjänen
Nuclear morphometry is of independent prognostic value only in T1 prostatic adenocarcinomas.
The Prostate 1995;27(2):110-7.
1995: Z R Zhu; M Parviainen; S Männistö; P Pietinen; Matti Eskelinen; Kari Syrjänen; Matti Uusitupa
Vitamin A concentration in breast adipose tissue of breast cancer patients.
Anticancer research 1995;15(4):1593-6.
1995: Sakari Hietanen; Seija Grénman; Kari Syrjänen; K Lappalainen; J Kauppinen; Thomas Carey; Stina Syrjänen
Human papillomavirus in vulvar and vaginal carcinoma cell lines.
British journal of cancer 1995;72(1):134-9.
1995: V Kärjä; Kari Syrjänen; Stina Syrjänen
Collagen IV and tenascin immunoreactivity as prognostic determinant in benign and malignant salivary gland tumours.
Acta oto-laryngologica 1995;115(4):569-75.
1995: T Pietiläinen; Pertti Lipponen; Sirpa Aaltomaa; Matti Eskelinen; Veli-Matti Kosma; Kari Syrjänen
Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival.
Anticancer research 1995;15(3):959-64.
1995: M Aaltonen; Pertti Lipponen; Veli-Matti Kosma; Sirpa Aaltomaa; Kari Syrjänen
Prognostic value of cathepsin-D expression in female breast cancer.
Anticancer research 1995;15(3):1033-7.
1995: Pertti Lipponen; Matti Eskelinen; Kari Syrjänen
Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma.
British journal of cancer 1995;71(4):863-7.
1995: F Chang; Stina Syrjänen; Kari Syrjänen
Implications of the p53 tumor-suppressor gene in clinical oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(4):1009-22.
1995: S Costa; Stina Syrjänen; C Vendra; F Chang; G Guida; M Hippeläinen; P Terzano; A Tervahauta; M Yliskoski; Kari Syrjänen
Human papillomavirus infections in vulvar precancerous lesions and cancer.
The Journal of reproductive medicine 1995;40(4):291-8.
1995: S Vesalainen; Pertti Lipponen; S Nordling; M Talja; Kari Syrjänen
Results of the primary treatment in T1-3M0 prostatic adenocarcinoma are dependent on tumour biology.
Anticancer research 1995;15(2):569-73.
1995: S Vesalainen; Pertti Lipponen; M Talja; Kari Syrjänen
Mitotic activity and prognosis in prostatic adenocarcinoma.
The Prostate 1995;26(2):80-6.
1995: Z R Zhu; Jyrki J Agren; S Männistö; P Pietinen; Matti Eskelinen; Kari Syrjänen; Matti Uusitupa
Fatty acid composition of breast adipose tissue in breast cancer patients and in patients with benign breast disease.
Nutrition and cancer 1995;24(2):151-60.
1995: S Lu; Kari Syrjänen; Väinö K Havu
No evidence of human papillomavirus DNA in actinic keratosis.
Archives of dermatological research 1995;287(7):649-51.
1995: S Vesalainen; Pertti Lipponen; M Talja; Kari Syrjänen
Biochemical parameters as prognostic factors in prostatic adenocarcinoma.
Acta oncologica (Stockholm, Sweden) 1995;34(1):53-9.
1995: T Pietiläinen; Pertti Lipponen; Sirpa Aaltomaa; Matti Eskelinen; Veli-Matti Kosma; Kari Syrjänen
Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival.
European journal of cancer (Oxford, England : 1990) 1995;31A(3):329-33.
1995: K Kurvinen; Sakari Hietanen; Kari Syrjänen; Stina Syrjänen
Rapid and effective detection of mutations in the p53 gene using nonradioactive single-strand conformation polymorphism (SSCP) technique applied on PhastSystem.
Journal of virological methods 1995;51(1):43-53.
1995: E Toropainen; Pertti Lipponen; Kari Syrjänen
Expression of insulin-like growth factor I (IGF-I) in female breast cancer as related to established prognostic factors and long-term prognosis.
European journal of cancer (Oxford, England : 1990) 1995;31A(9):1443-8.
1994: K Lappalainen; Arto Urtti; E Söderling; Ilpo Jääskeläinen; Kari Syrjänen; Stina Syrjänen
Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells.
Biochimica et biophysica acta 1994;1196(2):201-8.
1994: F Chang; Pertti Lipponen; A Tervahauta; Stina Syrjänen; Kari Syrjänen
Transitional cell carcinoma of the bladder: failure to demonstrate human papillomavirus deoxyribonucleic acid by in situ hybridization and polymerase chain reaction.
The Journal of urology 1994;152(5 Pt 1):1429-33.
1994: Pertti Lipponen; E Saarelainen; Hongxiu Ji; Sirpa Aaltomaa; Kari Syrjänen
Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer.
The Journal of pathology 1994;174(2):101-9.
1994: A Tervahauta; Stina Syrjänen; M Yliskoski; L I Gold; Kari Syrjänen
Expression of transforming growth factor-beta 1 and -beta 2 in human papillomavirus (HPV)-associated lesions of the uterine cervix.
Gynecologic oncology 1994;54(3):349-56.
1994: M I Hippeläinen; M Hippeläinen; S Saarikoski; Kari Syrjänen
Clinical course and prognostic factors of human papillomavirus infections in men.
Sexually transmitted diseases 1994;21(5):272-9.
1994: F Chang; Stina Syrjänen; A Tervahauta; K Kurvinen; L Wang; Kari Syrjänen
Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.
British journal of cancer 1994;70(2):346-51.
1994: S Vesalainen; S Nordling; Pertti Lipponen; M Talja; Kari Syrjänen
Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
British journal of cancer 1994;70(2):309-14.
1994: Outi Kopra; Hilkka Soininen; Stina Syrjänen; H Neittaanmäki; Leo Paljärvi; O Kosunen; Kari Syrjänen; PJ Riekkinen
beta-Amyloid protein immunoreactivity in skin is not a reliable marker of Alzheimer's disease. An autopsy-controlled study.
Archives of neurology 1994;51(8):799-804.
1994: K Lappalainen; Ilpo Jääskeläinen; Kari Syrjänen; Arto Urtti; Stina Syrjänen
Comparison of cell proliferation and toxicity assays using two cationic liposomes.
Pharmaceutical research 1994;11(8):1127-31.
1994: A Tervahauta; Stina Syrjänen; Kari Syrjänen
Epidermal growth factor receptor, c-erbB-2 proto-oncogene and estrogen receptor expression in human papillomavirus lesions of the uterine cervix.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1994;13(3):234-40.
1994: V Kärjä; Stina Syrjänen; V Kataja; Kari Syrjänen
c-erbB-2 oncogene expression in salivary gland tumours.
ORL; journal for oto-rhino-laryngology and its related specialties 1994;56(4):206-12.
1994: Pertti Lipponen; Matti Eskelinen; K Hietala; Kari Syrjänen; R A Gambetta
Expression of proliferating cell nuclear antigen (PC10), p53 protein and c-erbB-2 in renal adenocarcinoma.
International journal of cancer. Journal international du cancer 1994;57(2):275-80.
1994: M I Hippeläinen; M Yliskoski; Stina Syrjänen; J Saastamoinen; M Hippeläinen; S Saarikoski; Kari Syrjänen
Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners.
Sexually transmitted diseases 1994;21(2):76-82.
1994: S Vesalainen; Pertti Lipponen; M Talja; Esko Alhava; Kari Syrjänen
Tumor vascularity and basement membrane structure as prognostic factors in T1-2MO prostatic adenocarcinoma.
Anticancer research 1994;14(2B):709-14.
1994: K Lappalainen; Arto Urtti; Ilpo Jääskeläinen; Kari Syrjänen; Stina Syrjänen
Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 E7 mRNA in CaSki cells.
Antiviral research 1994;23(2):119-30.
1994: K Kurvinen; A Tervahauta; Stina Syrjänen; F Chang; Kari Syrjänen
The state of the p53 gene in human papillomavirus (HPV)-positive and HPV-negative genital precancer lesions and carcinomas as determined by single-strand conformation polymorphism analysis and sequencing.
Anticancer research 1994;14(1A):177-81.
1994: Pertti Lipponen; Hongxiu Ji; Sirpa Aaltomaa; Kari Syrjänen
Tumour vascularity and basement membrane structure in breast cancer as related to tumour histology and prognosis.
Journal of cancer research and clinical oncology 1994;120(11):645-50.
1994: S Vesalainen; Pertti Lipponen; M Talja; Kari Syrjänen
Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma.
European journal of cancer (Oxford, England : 1990) 1994;30A(12):1797-803.
1994: Pertti Lipponen; Sirpa Aaltomaa; Veli-Matti Kosma; Kari Syrjänen
Apoptosis in breast cancer as related to histopathological characteristics and prognosis.
European journal of cancer (Oxford, England : 1990) 1994;30A(14):2068-73.
1993: F Chang; Stina Syrjänen; Q Shen; L Wang; Kari Syrjänen
Screening for human papillomavirus infections in esophageal squamous cell carcinomas by in situ hybridization.
Cancer 1993;72(9):2525-30.
1993: Pertti Lipponen; Sirpa Aaltomaa; S Papinaho; Kari Syrjänen
Nucleolar organizer regions in myofibroblasts in breast cancer. Relation to cancer cell morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis.
Pathology, research and practice 1993;189(9):1030-5.
1993: V Kataja; Stina Syrjänen; M Yliskoski; M Hippelïnen; M Väyrynen; S Saarikoski; Rauno Mäntyjärvi; V Jokela; J T Salonen; Kari Syrjänen
Risk factors associated with cervical human papillomavirus infections: a case-control study.
American journal of epidemiology 1993;138(9):735-45.
1993: M Hippeläinen; Stina Syrjänen; M Hippeläinen; H Koskela; J Pulkkinen; S Saarikoski; Kari Syrjänen
Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts.
Sexually transmitted diseases 1993;20(6):321-8.
1993: Matti Eskelinen; Pertti Lipponen; L Aitto-Oja; O Hall; Kari Syrjänen
The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma.
International journal of cancer. Journal international du cancer 1993;55(4):547-54.
1993: F Chang; Stina Syrjänen; A Tervahauta; Kari Syrjänen
Tumourigenesis associated with the p53 tumour suppressor gene.
British journal of cancer 1993;68(4):653-61.
1993: Pertti Lipponen; Sirpa Aaltomaa; Kari Syrjänen
Morphometric quantitation of nucleolar organizer region proteins in breast carcinoma.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1993;15(5):311-6.
1993: M I Hippeläinen; Stina Syrjänen; M J Hippeläinen; S Saarikoski; Kari Syrjänen
Diagnosis of genital human papillomavirus (HPV) lesions in the male: correlation of peniscopy, histology and in situ hybridisation.
Genitourinary medicine 1993;69(5):346-51.
1993: Pertti Lipponen; Hongxiu Ji; Sirpa Aaltomaa; Stina Syrjänen; Kari Syrjänen
p53 protein expression in breast cancer as related to histopathological characteristics and prognosis.
International journal of cancer. Journal international du cancer 1993;55(1):51-6.
1993: H J Lipponen; Sirpa Aaltomaa; Stina Syrjänen; Kari Syrjänen
c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
Anticancer research 1993;13(4):1147-52.
1993: M Hippeläinen; Matti Eskelinen; Pertti Lipponen; F Chang; Kari Syrjänen
Mitotic activity index, volume corrected mitotic index and human papilloma-virus suggestive morphology are not prognostic factors in carcinoma of the oesophagus.
Anticancer research 1993;13(3):677-81.
1993: Sirpa Aaltomaa; Pertti Lipponen; Kari Syrjänen
Nucleolar organizer regions related to morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis in female breast cancer.
Pathology, research and practice 1993;189(4):416-21.
1993: Sirpa Aaltomaa; Pertti Lipponen; Kari Syrjänen
Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in axillary lymph node negative breast cancer.
Anticancer research 1993;13(2):533-8.
1993: F Chang; Stina Syrjänen; K Kurvinen; Kari Syrjänen
The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
The American journal of gastroenterology 1993;88(2):174-86.
1993: Outi Kopra; Stina Syrjänen; Hilkka Soininen; S Talasniemi; M Kaski; R Mäntyjärvi; Kari Syrjänen; PJ Riekkinen
Circulating immune complexes in sera from patients with Alzheimer's disease, multi-infarct dementia and Down's syndrome.
Neuroscience letters 1993;149(1):67-70.
1993: Sirpa Aaltomaa; Pertti Lipponen; Matti Eskelinen; Veli-Matti Kosma; S Marin; Esko Alhava; Kari Syrjänen
Predictive value of a morphometric prognostic index in female breast cancer.
Oncology 1993;50(1):57-62.
1993: Sirpa Aaltomaa; Pertti Lipponen; S Papinaho; Kari Syrjänen
Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer.
Journal of cancer research and clinical oncology 1993;119(5):288-94.
1992: Matti Eskelinen; M Hippeläinen; E Salmela; H Paajanen; Esko Alhava; Kari Syrjänen
A prospective study of tissue polypeptide specific antigen (TPS) in breast cancer diagnosis.
Anticancer research 1992;12(6B):2033-6.
1992: Piero Tosi; Marcella Cintorino; Rosa Santopietro; R Lio; Paolo Barbini; Hongxiu Ji; F Chang; V Kataja; Stina Syrjänen; Kari Syrjänen
Prognostic factors in invasive cervical carcinomas associated with human papillomavirus (HPV). Quantitative data and cytokeratin expression.
Pathology, research and practice 1992;188(7):866-73.
1992: Matti Eskelinen; Pertti Lipponen; Kari Syrjänen
Nucleolar organiser regions (AgNORs) related to histopathological characteristics and survival in prostatic adenocarcinoma.
Anticancer research 1992;12(5):1635-40.
1992: Pertti Lipponen; S Papinaho; Matti Eskelinen; P J Klemi; Sirpa Aaltomaa; Veli-Matti Kosma; S Marin; Kari Syrjänen
DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer.
Anticancer research 1992;12(5):1533-8.
1992: S Costa; Stina Syrjänen; C Vendra; F Chang; G Guida; A Tervahauta; M Hippeläinen; Kari Syrjänen
Detection of human papillomavirus infections in the male sexual partners of women attending an STD clinic in Bologna.
International journal of STD & AIDS 1992;3(5):338-46.
1992: Maria Halmekytö; Kari Syrjänen; Juhani Jänne; Leena Alhonen
Enhanced papilloma formation in response to skin tumor promotion in transgenic mice overexpressing the human ornithine decarboxylase gene.
Biochemical and biophysical research communications 1992;187(1):493-7.
1992: Pertti Lipponen; Sirpa Aaltomaa; Matti Eskelinen; Veli-Matti Kosma; S Marin; Kari Syrjänen
The changing importance of prognostic factors in breast cancer during long-term follow-up.
International journal of cancer. Journal international du cancer 1992;51(5):698-702.
1992: Matti Eskelinen; Pertti Lipponen; Sirpa Aaltomaa; Veli-Matti Kosma; Kari Syrjänen; Esko Alhava
Breast cancer in young women: clinical, histological and morphometric prognostic factors.
Anticancer research 1992;12(4):1237-42.
1992: Sirpa Aaltomaa; Pertti Lipponen; Kari Syrjänen
Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining.
Anticancer research 1992;12(4):1281-6.
1992: F Chang; Stina Syrjänen; Q Shen; L Wang; D Wang; Kari Syrjänen
Human papillomavirus involvement in esophageal precancerous lesions and squamous cell carcinomas as evidenced by microscopy and different DNA techniques.
Scandinavian journal of gastroenterology 1992;27(7):553-63.
1992: Matti Eskelinen; Pertti Lipponen; S Papinaho; Sirpa Aaltomaa; Veli-Matti Kosma; P Klemi; Kari Syrjänen
DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer.
International journal of cancer. Journal international du cancer 1992;51(4):555-61.
1992: Stina Syrjänen; P Kallio; P Sainio; C Fuju; Kari Syrjänen
Epstein-Barr virus (EBV) genomes and c-myc oncogene in oral Burkitt's lymphomas.
Scandinavian journal of dental research 1992;100(3):176-80.
1992: Pertti Lipponen; Matti Eskelinen; S Papinaho; P J Klemi; Sirpa Aaltomaa; Veli-Matti Kosma; S Marin; Kari Syrjänen
Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer.
Anticancer research 1992;12(3):677-82.
1992: V Kataja; Stina Syrjänen; Rauno Mäntyjärvi; M Yliskoski; S Saarikoski; Kari Syrjänen
Prognostic factors in cervical human papillomavirus infections.
Sexually transmitted diseases 1992;19(3):154-60.
1992: Stina Syrjänen; B Andersson; L Juntunen; Kari Syrjänen
Polymerase chain reaction for producing biotinylated human papillomavirus DNA probes for in situ hybridization.
Sexually transmitted diseases 1992;19(3):140-5.
1992: M Yliskoski; A Tervahauta; S Saarikoski; Rauno Mäntyjärvi; Kari Syrjänen
Clinical course of cervical human papillomavirus lesions in relation to coexistent cervical infections.
Sexually transmitted diseases 1992;19(3):137-9.
1992: Kari Syrjänen; V Kataja; M Yliskoski; F Chang; Stina Syrjänen; S Saarikoski
Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System.
Obstetrics and gynecology 1992;79(5 ( Pt 1)):675-82.
1992: Kari Tuppurainen; A Raninen; O Kosunen; J P Kankkunen; Jari K Kellokoski; Stina Syrjänen; Maija Mäntyjärvi; Kari Syrjänen
Squamous cell carcinoma of the conjunctiva. Failure to demonstrate HPV DNA by in situ hybridization and polymerase chain reaction.
Acta ophthalmologica 1992;70(2):248-54.
1992: O Heinonen; Stina Syrjänen; R Mäntyjärvi; Kari Syrjänen; PJ Riekkinen
JC virus infection and Alzheimer's disease: reappraisal of an in situ hybridization approach.
Annals of neurology 1992;31(4):439-41.
1992: Sirpa Aaltomaa; Pertti Lipponen; S Papinaho; P Klemi; Veli-Matti Kosma; S Marin; Matti Eskelinen; Esko Alhava; Kari Syrjänen
Nuclear morphometry and DNA flow cytometry as prognostic factors in female breast cancer.
The European journal of surgery = Acta chirurgica 1992;158(3):135-41.
1992: Jari K Kellokoski; Stina Syrjänen; M Yliskoski; Kari Syrjänen
Dot blot hybridization in detection of human papillomavirus (HPV) infections in the oral cavity of women with genital HPV infections.
Oral microbiology and immunology 1992;7(1):19-23.
1992: Hilkka Soininen; Stina Syrjänen; Outi Kopra; H Neittaanmäki; Riitta Miettinen; Leo Paljärvi; Kari Syrjänen; Konrad Beyreuther; PJ Riekkinen
Amyloid beta-protein deposition in skin of patients with dementia.
Lancet 1992;339(8787):245.
1992: Matti Eskelinen; Pertti Lipponen; Kari Syrjänen
Expression of tumour markers CA50, CEA and TPA in female breast carcinoma as related to histopathological findings and survival.
Anticancer research 1992;12(1):91-5.
1992: Sirpa Aaltomaa; Pertti Lipponen; Matti Eskelinen; Veli-Matti Kosma; S Marin; Esko Alhava; Kari Syrjänen
Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymph-node-positive breast cancer.
European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes 1992;24(3):160-8.
1991: Hongxiu Ji; M Yliskoski; M Väyrynen; M Hippeläinen; Stina Syrjänen; Kari Syrjänen
Colposcopic analysis of genital human papillomavirus infections during an 8-year prospective follow-up.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 1991;36(4):291-300.
1991: P Kallio; Stina Syrjänen; A Tervahauta; Kari Syrjänen
A simple method for isolation of DNA from formalin-fixed paraffin-embedded samples for PCR.
Journal of virological methods 1991;35(1):39-47.
1991: Maria Halmekytö; Juha Hyttinen; Riitta Sinervirta; M Utriainen; S Myöhänen; H M Voipio; Jarmo Wahlfors; S Syrjänen; Kari Syrjänen; Leena Alhonen
Transgenic mice aberrantly expressing human ornithine decarboxylase gene.
The Journal of biological chemistry 1991;266(29):19746-51.
1991: M Yliskoski; Kari Syrjänen; Stina Syrjänen; S Saarikoski; A Nethersell
Systemic alpha-interferon (Wellferon) treatment of genital human papillomavirus (HPV) type 6, 11, 16, and 18 infections: double-blind, placebo-controlled trial.
Gynecologic oncology 1991;43(1):55-60.
1991: Stina Syrjänen; O Heinonen; Riitta Miettinen; Leo Paljärvi; Kari Syrjänen; PJ Riekkinen
Short biotinylated oligonucleotides bind non-specifically to senile plaques of Alzheimer's disease.
Neuroscience letters 1991;130(1):89-91.
1991: Matti Eskelinen; Pertti Lipponen; Kari Syrjänen
TAG 12 expression as a prognostic factor in female breast cancer.
Anticancer research 1991;11(5):1683-6.
1991: A Tervahauta; Matti Eskelinen; Stina Syrjänen; Pertti Lipponen; P Pajarinen; Kari Syrjänen
Immunohistochemical demonstration of c-erb B-2 oncoprotein expression in female breast cancer and its prognostic significance.
Anticancer research 1991;11(5):1677-81.
1991: M Hippeläinen; M Yliskoski; S Saarikoski; Stina Syrjänen; Kari Syrjänen
Genital human papillomavirus lesions of the male sexual partners: the diagnostic accuracy of peniscopy.
Genitourinary medicine 1991;67(4):291-6.
1991: F Chang; Stina Syrjänen; Jari K Kellokoski; Kari Syrjänen
Human papillomavirus (HPV) infections and their associations with oral disease.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1991;20(7):305-17.
1991: Sirpa Aaltomaa; Pertti Lipponen; Matti Eskelinen; Esko Alhava; Kari Syrjänen
Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
The European journal of surgery = Acta chirurgica 1991;157(5):319-24.
1991: F Chang; Esko Janatuinen; PH Pikkarainen; Stina Syrjänen; Kari Syrjänen
Esophageal squamous cell papillomas. Failure to detect human papillomavirus DNA by in situ hybridization and polymerase chain reaction.
Scandinavian journal of gastroenterology 1991;26(5):535-43.
1991: Stina Syrjänen; B Andersson; L Juntunen; Kari Syrjänen
The use of polymerase chain reaction in generation of biotinylated human papillomavirus DNA probes for in situ hybridization.
Journal of virological methods 1991;31(2-3):147-59.
1991: Matti Eskelinen; Pertti Lipponen; R Majapuro; Kari Syrjänen
Prognostic factors in prostatic adenocarcinoma assessed by means of quantitative histology.
European urology 1991;19(4):274-8.
1991: M Yliskoski; S Saarikoski; Kari Syrjänen
Conization for CIN associated with human papillomavirus infection.
Archives of gynecology and obstetrics 1991;249(2):59-65.
1991: Jari K Kellokoski; Stina Syrjänen; Piero Tosi; Marcella Cintorino; P Leoncini; Kari Syrjänen
Cytokeratin pattern in normal and HPV infected oral mucosa in women with genital HPV infections.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1991;20(1):26-31.
1991: Pertti Lipponen; Matti Eskelinen; Stina Syrjänen; A Tervahauta; Kari Syrjänen
Use of immunohistochemically demonstrated c-erb B-2 oncoprotein expression as a prognostic factor in transitional cell carcinoma of the urinary bladder.
European urology 1991;20(3):238-42.
1990: Kari Syrjänen; M Yliskoski; V Kataja; M Hippeläinen; Stina Syrjänen; S Saarikoski; A Ryhänen
Prevalence of genital human papillomavirus infections in a mass-screened Finnish female population aged 20-65 years.
International journal of STD & AIDS 1990;1(6):410-5.
1990: F Chang; O Kosunen; Veli-Matti Kosma; Stina Syrjänen; J Lahtinen; Kari Syrjänen
Verrucous carcinoma of the anus containing human papillomavirus type 16 DNA detected by in situ hybridisation: a case report.
Genitourinary medicine 1990;66(5):342-5.
1990: A Laatikainen; H Sarkkinen; Kari Syrjänen; Rauno Mäntyjärvi
Local immune reaction in syngeneic mice against tumorigenic and nontumorigenic BPV-transformed mouse cell lines.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1990;98(10):909-15.
1990: Stina Syrjänen; J Saastamoinen; F J Chang; Hongxiu Ji; Kari Syrjänen
Colposcopy, punch biopsy, in situ DNA hybridization, and the polymerase chain reaction in searching for genital human papillomavirus (HPV) infections in women with normal PAP smears.
Journal of medical virology 1990;31(4):259-66.
1990: Jari K Kellokoski; Stina Syrjänen; V Kataja; M Yliskoski; Kari Syrjänen
Acetowhite staining and its significance in diagnosis of oral mucosal lesions in women with genital HPV infections.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1990;19(6):278-83.
1990: F Chang; Q Shen; J Zhou; C Wang; D Wang; Stina Syrjänen; Kari Syrjänen
Detection of human papillomavirus DNA in cytologic specimens derived from esophageal precancer lesions and cancer.
Scandinavian journal of gastroenterology 1990;25(4):383-8.
1990: V Kataja; Kari Syrjänen; Stina Syrjänen; Rauno Mäntyjärvi; M Yliskoski; S Saarikoski; J T Salonen
Prospective follow-up of genital HPV infections: survival analysis of the HPV typing data.
European journal of epidemiology 1990;6(1):9-14.
1990: M Yliskoski; K Cantell; Kari Syrjänen; Stina Syrjänen
Topical treatment with human leukocyte interferon of HPV 16 infections associated with cervical and vaginal intraepithelial neoplasias.
Gynecologic oncology 1990;36(3):353-7.
1990: Jari K Kellokoski; Stina Syrjänen; Kari Syrjänen; M Yliskoski
Oral mucosal changes in women with genital HPV infection.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1990;19(3):142-8.
1990: F Chang; Stina Syrjänen; Q Shen; Hongxiu Ji; Kari Syrjänen
Human papillomavirus (HPV) DNA in esophageal precancer lesions and squamous cell carcinomas from China.
International journal of cancer. Journal international du cancer 1990;45(1):21-5.
1990: Kari Syrjänen; Stina Syrjänen
Epidemiology of human papilloma virus infections and genital neoplasia.
Scandinavian journal of infectious diseases. Supplementum 1990;69():7-17.
1990: Stina Syrjänen; V Kärjä; F J Chang; B Johansson; Kari Syrjänen
Epstein-Barr virus involvement in salivary gland lesions associated with Sjögren's syndrome.
ORL; journal for oto-rhino-laryngology and its related specialties 1990;52(4):254-9.
1990: Hongxiu Ji; Stina Syrjänen; Kari Syrjänen; A R Wu; F J Chang
In situ hybridization analysis of HPV DNA in cervical precancer and cervical cancers from China.
Archives of gynecology and obstetrics 1990;247(1):21-9.
1990: Kari Syrjänen; M Hakama; S Saarikoski; M Väyrynen; M Yliskoski; Stina Syrjänen; V Kataja; O Castrén
Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population.
Sexually transmitted diseases 1990;17(1):15-9.
1990: A Laatikainen; H Karjalainen; H Sarkkinen; Kari Syrjänen; Rauno Mäntyjärvi
Generation of cell-mediated cytotoxicity against bovine-papilloma-virus-transformed primary mouse cell lines.
Cancer immunology, immunotherapy : CII 1990;30(6):351-6.
1990: F Chang; Stina Syrjänen; Q Shen; Hongxiu Ji; Kari Syrjänen
Detection of human papillomavirus (HPV) in genital warts and carcinomas by DNA in situ hybridization in Chinese patients.
Cytopathology : official journal of the British Society for Clinical Cytology 1990;1(2):97-103.
1990: F Chang; Stina Syrjänen; J Nuutinen; J Kärjä; Kari Syrjänen
Detection of human papillomavirus (HPV) DNA in oral squamous cell carcinomas by in situ hybridization and polymerase chain reaction.
Archives of dermatological research 1990;282(8):493-7.
1990: P Leoncini; Roberto Petracca; Paolo Ruggiero; Marcella Cintorino; Stina Syrjänen; Rauno Mäntyjärvi; Kari Syrjänen
Expression of cytokeratin No. 19 polypeptide in genital papillomavirus lesions.
Gynecologic and obstetric investigation 1990;29(1):59-66.
1989: Maija Mäntyjärvi; Stina Syrjänen; S Kaipiainen; Rauno Mäntyjärvi; T Kahlos; Kari Syrjänen
Detection of human papillomavirus type 11 DNA in a conjunctival squamous cell papilloma by in situ hybridization with biotinylated probes.
Acta ophthalmologica 1989;67(4):425-9.
1989: Stina Syrjänen; G von Krogh; Jari K Kellokoski; Kari Syrjänen
Two different human papillomavirus (HPV) types associated with oral mucosal lesions in an HIV-seropositive man.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1989;18(6):366-70.
1989: P J Klemi; H Joensuu; L Siivonen; E Virolainen; Stina Syrjänen; Kari Syrjänen
Association of DNA aneuploidy with human papillomavirus-induced malignant transformation of sinonasal transitional papillomas.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1989;100(6):563-7.
1989: S Parkkinen; Rauno Mäntyjärvi; Kari Syrjänen; A C Syvänen; M Ranki
Sandwich hybridization in solution: a rapid method to screen HPV 16 DNA in cervical scrapes.
Molecular and cellular probes 1989;3(1):1-11.
1989: V Kataja; Kari Syrjänen; Rauno Mäntyjärvi; M Väyrynen; Stina Syrjänen; S Saarikoski; S Parkkinen; M Yliskoski; J T Salonen; O Castren
Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data.
European journal of epidemiology 1989;5(1):1-7.
1989: M Yliskoski; S Saarikoski; Kari Syrjänen; Stina Syrjänen; O Castrén
Cryotherapy and CO2-laser vaporization in the treatment of cervical and vaginal human papillomavirus (HPV) infections.
Acta obstetricia et gynecologica Scandinavica 1989;68(7):619-25.
1989: Kari Syrjänen; Stina Syrjänen
Concept of the existence of human papillomavirus (HPV) DNA in histologically normal squamous epithelium of the genital tract should be re-evaluated.
Acta obstetricia et gynecologica Scandinavica 1989;68(7):613-7.
1989: Kari Syrjänen; Stina Syrjänen; Jari K Kellokoski; J Kärjä; Rauno Mäntyjärvi
Human papillomavirus (HPV) type 6 and 16 DNA sequences in bronchial squamous cell carcinomas demonstrated by in situ DNA hybridization.
Lung 1989;167(1):33-42.
1988: Kari Syrjänen; Rauno Mäntyjärvi; S Saarikoski; M Väyrynen; Stina Syrjänen; S Parkkinen; M Yliskoski; J Saastamoinen; O Castren
Factors associated with progression of cervical human papillomavirus (HPV) infections into carcinoma in situ during a long-term prospective follow-up.
British journal of obstetrics and gynaecology 1988;95(11):1096-102.
1988: S Parkkinen; Stina Syrjänen; Kari Syrjänen; M Yliskoski; J Tenhunen; Rauno Mäntyjärvi; M Ranki
Screening of premalignant cervical lesions for HPV 16 DNA by sandwich and in situ hybridization techniques.
Gynecologic oncology 1988;30(2):251-64.
1988: Stina Syrjänen; P Partanen; Rauno Mäntyjärvi; Kari Syrjänen
Sensitivity of in situ hybridization techniques using biotin- and 35S-labeled human papillomavirus (HPV) DNA probes.
Journal of virological methods 1988;19(3-4):225-38.
1988: Rauno Mäntyjärvi; H Sarkkinen; S Parkkinen; A Laatikainen; A Ryhänen; Kari Syrjänen
Tumorigenicity of primary mouse fibroblasts transformed by bovine papillomavirus type 1.
Intervirology 1988;29(6):311-9.
1988: T Sorvari; A Sarnesto; Kari Syrjänen
Type IV collagen in the basal membrane of human papillomavirus associated premalignant and malignant squamous cell lesions of the uterine cervix.
Gynecologic and obstetric investigation 1988;26(4):324-31.
1988: R A Mäntyjärvi; H Sarkkinen; H Karajalainen; S Parkkinen; A Ryhänen; Kari Syrjänen; H Jägerroos; T Nurmi
Tumour-associated antigens in primary mouse fibroblasts induced by transformation with bovine papillomavirus type 1.
Experimental pathology 1988;35(1):25-33.
1988: Piero Tosi; Pietro Luzi; Rosa Santopietro; Clelia Miracco; R Lio; Stina Syrjänen; Rauno Mäntyjärvi; Kari Syrjänen
Morphometric assessment of the biological potential of human papillomavirus infections in the uterine cervix.
Applied pathology 1988;6(4):247-57.
1988: Rauno Mäntyjärvi; H Sarkkinen; S Parkkinen; A Ryhänen; H Karjalainen; Kari Syrjänen; Stina Syrjänen
Phenotypic transformation of primary mouse fibroblasts by BPV 1 DNA.
Archives of virology 1988;100(1-2):17-25.
1988: Marcella Cintorino; Stina Syrjänen; P Leoncini; E Bellizzi De Marco; Roberto Petracca; Vitaliano Pallini; Piero Tosi; Rauno Mäntyjärvi; Kari Syrjänen
Altered expression of filaggrin in human papillomavirus (HPV) lesions of the uterine cervix.
Archives of gynecology and obstetrics 1988;241(4):235-47.
1987: Stina Syrjänen; R P Happonen; E Virolainen; L Siivonen; Kari Syrjänen
Detection of human papillomavirus (HPV) structural antigens and DNA types in inverted papillomas and squamous cell carcinomas of the nasal cavities and paranasal sinuses.
Acta oto-laryngologica 1987;104(3-4):334-41.
1987: A Laatikainen; Kari Syrjänen; Rauno Mäntyjärvi; Piero Tosi
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity.
Archiv für Geschwulstforschung 1987;57(4):265-74.
1987: A Laatikainen; Kari Syrjänen; Rauno Mäntyjärvi; Piero Tosi
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. IV. Lymph node immunoreactivity and cell-mediated cytotoxicity.
Neoplasma 1987;34(4):431-9.
1987: Piero Tosi; Kari Syrjänen; Marcella Cintorino; Rauno Mäntyjärvi; P Luzi; C Miracco; A Laatikainen; L Leoncini; Rosa Santopietro
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. III. Morphometric assessment of the dynamic changes in post-capillary venules as regulatory elements of lymphocyte recirculation in tumor-draining lymph nodes.
Archiv für Geschwulstforschung 1987;57(1):7-15.
1986: Kari Syrjänen; Piero Tosi; Marcella Cintorino; Rauno Mäntyjärvi; P Luzi; L Leoncini; A Laatikainen; C Miracco; Rosa Santopietro
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. II. Morphometric assessment of immunoreactivity in the thymus and spleen related to lymphocyte subsets in peripheral blood.
Experimental pathology 1986;30(2):75-82.
1986: Piero Tosi; Kari Syrjänen; Marcella Cintorino; Rauno Mäntyjärvi; P Luzi; C Miracco; A Laatikainen; L Leoncini; Rosa Santopietro
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. I. Morphometric assessment of lymph node immunoreactivity and analysis of circulating antibodies.
Experimental pathology 1986;30(2):65-74.
1986: Kari Syrjänen; M Väyrynen; Rauno Mäntyjärvi; O Castren; S Saarikoski
Natural killer (NK) cells with HNK-1 phenotype in the cervical biopsies of women followed-up for human papillomavirus (HPV) lesions.
Acta obstetricia et gynecologica Scandinavica 1986;65(2):139-45.
1985: Kari Syrjänen; M Väyrynen; S Saarikoski; Rauno Mäntyjärvi; S Parkkinen; M Hippeläinen; O Castren
Natural history of cervical human papillomavirus (HPV) infections based on prospective follow-up.
British journal of obstetrics and gynaecology 1985;92(11):1086-92.
1985: Kari Syrjänen; E M de Villiers; S Saarikoski; O Castren; M Väyrynen; Rauno Mäntyjärvi; S Parkkinen
Cervical papillomavirus infection progressing to invasive cancer in less than three years.
Lancet 1985;1(8427):510-1.
1985: Kari Syrjänen; M Väyrynen; M Hippeläinen; O Castrén; S Saarikoski; Rauno Mäntyjärvi
Electron microscopic assessment of cervical punch biopsies in women followed-up for human papillomavirus (HPV) lesions.
Archiv für Geschwulstforschung 1985;55(2):131-8.
1981: M Väyrynen; T Romppanen; E Koskela; O Castren; Kari Syrjänen
Verrucous squamous cell carcinoma of the female genital tract. Report of three cases and survey of the literature.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 1981;19(5):351-6.